Cardiologist sentenced to prison, fined $25K for illegally distributing Oxycodone

A 60-year-old New Jersey cardiologist has been sentenced to 30 months in prison for illegally prescribing and distributing Oxycodone pills.

Raymond Catania, DO, first admitted to prescribing and distributing thousands of Oxycodone pills in March 2021. At the time, authorities said the doctor could face up to 20 years in prison for his actions.

From January 2016 through March 2017, Catania issued prescriptions for thousands of Oxycodone pills to one of his patients, and Catania did so without a legitimate medical purpose and outside of the usual course of professional practice,” according to a prepared statement from the U.S. Department of Justice. “Catania also issued prescriptions for thousands of Oxycodone pills to that patient’s wife even though the wife was not Catania’s patient. Oxycodone—a Schedule II controlled substance—has a high potential for abuse that can lead to severe psychological and physical dependence and can result in fatal overdoses.”

In addition to the 30-month prison sentence, Catania has been fined $25,000. He was also sentenced to three years of supervised release.

U.S. Attorney Rachael A. Honig announced the sentencing, crediting the Federal Bureau of Investigation for their assistance throughout the investigation. U.S. District Judge Michael A. Shipp handed down the sentencing.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday.